论文部分内容阅读
Pancreatic ductal adenocarcinoma （PDAC） is one ofthe most aggressive cancers with a grim overall 5-yearsurvival rate of 5%. Advances in surgical techniques,critical care, molecular diagnosis, diagnostic imaging,endosonology and adjuvant therapy have impro